Clinical Drug Experience Knowledgebase

177lu-psma-617 (1 trial)

abemaciclib (verzenio) (1 trial)

carboplatin (paraplatin) (1 trial)

docetaxel (taxotere) (2 trials)

dutasteride (avodart) (1 trial)

enzalutamide (xtandi) (1 trial)

human fecal microbiota (1 trial)

ketoconazole (nizoral) (1 trial)

lapatinib (tykerb) (1 trial)

pembrolizumab (keytruda) (2 trials)

ptvg-ar (1 trial)

ptvg-hp (1 trial)

sargramostim (leukine) (2 trials)

satraplatin (1 trial)

seviteronel (1 trial)

talazoparib (talzenna) (1 trial)

telaglenastat (1 trial)

urea (1 trial)

burixafor hydrobromide (1 trial)

cemiplimab (libtayo) (1 trial)

ipilimumab (yervoy) (1 trial)

radium-223 (xofigo) (1 trial)

cabozantinib (cometriq) (1 trial)